HeartSine Technologies
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Series A | ||
£2.0m | Series B | ||
N/A | Acquisition | ||
Total Funding | €2.4m |
Related Content
Recent News about HeartSine Technologies
EditHeartSine, a subsidiary of Stryker Corporation, specializes in the development and manufacturing of automated external defibrillators (AEDs). These devices are designed to provide life-saving interventions in cases of sudden cardiac arrest. HeartSine's AEDs are known for their clinical advancements and intuitive design, making them suitable for use in workplaces, public access areas, and homes. The company operates in the medical device market, serving a diverse range of clients including businesses, public institutions, and individual consumers. HeartSine generates revenue through the sale of its AED devices and related accessories, as well as through service and maintenance contracts. The company's business model focuses on innovation and user-friendly technology, which is evident in their HeartSine Connected AEDs featuring HeartSine Gateway for enhanced readiness and connectivity.
Keywords: AEDs, defibrillators, cardiac arrest, medical devices, workplace safety, public access, home use, clinical advancements, connectivity, HeartSine Gateway.